Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Hammond

Showing results (31-40 of 136) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|February 7, 1981
Central nervous system prophylaxis in leukaemiaM E Nesbit, G J D'Angio, H N Sather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Three versus five years of maintenance therapy are equivalent in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study GroupD R Miller, S L Leikin, V C Albo, et al.
Medical and Pediatric Oncology|January 1, 1986
The staging of childhood acute lymphoblastic leukemia: strategies of the Childrens Cancer Study Group and a three-dimensional technic of multivariate analysisW A Bleyer, H Sather, P Coccia, et al.
Leukemia Research|January 1, 1990
Acute monoblastic leukemia: a unique subtype--a review from the Childrens Cancer Study GroupL F Odom, B C Lampkin, R Tannous, et al.
Nature|April 1, 2016
Measurement of the Earth tides with a MEMS gravimeterR P Middlemiss, A Samarelli, D J Paul, et al.
Cancer|January 1, 1978
The team approach to the management of pediatric cancerG D Hammond, W A Bleyer, J R Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1983
Randomized study of 3 years versus 5 years of chemotherapy in childhood acute lymphoblastic leukemiaM E Nesbit, H N Sather, L L Robison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapyK K Matthay, H N Sather, R C Seeger, et al.
Journal of Pediatric Surgery|February 1, 1989
Improvement in survival after excision of primary tumor in stage III neuroblastomaG M Haase, K Y Wong, A A deLorimier, et al.
Journal of Neuro-Oncology|August 1, 1990
A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Childrens Cancer Study GroupL J Ettinger, N Ru, M Krailo, et al.
Pageof 14

Showing results (31-40 of 136) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|February 7, 1981
Central nervous system prophylaxis in leukaemiaM E Nesbit, G J D'Angio, H N Sather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Three versus five years of maintenance therapy are equivalent in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study GroupD R Miller, S L Leikin, V C Albo, et al.
Medical and Pediatric Oncology|January 1, 1986
The staging of childhood acute lymphoblastic leukemia: strategies of the Childrens Cancer Study Group and a three-dimensional technic of multivariate analysisW A Bleyer, H Sather, P Coccia, et al.
Leukemia Research|January 1, 1990
Acute monoblastic leukemia: a unique subtype--a review from the Childrens Cancer Study GroupL F Odom, B C Lampkin, R Tannous, et al.
Nature|April 1, 2016
Measurement of the Earth tides with a MEMS gravimeterR P Middlemiss, A Samarelli, D J Paul, et al.
Cancer|January 1, 1978
The team approach to the management of pediatric cancerG D Hammond, W A Bleyer, J R Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1983
Randomized study of 3 years versus 5 years of chemotherapy in childhood acute lymphoblastic leukemiaM E Nesbit, H N Sather, L L Robison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapyK K Matthay, H N Sather, R C Seeger, et al.
Journal of Pediatric Surgery|February 1, 1989
Improvement in survival after excision of primary tumor in stage III neuroblastomaG M Haase, K Y Wong, A A deLorimier, et al.
Journal of Neuro-Oncology|August 1, 1990
A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Childrens Cancer Study GroupL J Ettinger, N Ru, M Krailo, et al.
Pageof 14